Kunal Kapoor with Ketto Co-founders Launch Metabolic Health Startup MetaGO

Beyond his acting career, Kunal Kapoor has also established himself as an entrepreneur and active angel investor, backing startups.

Rosalin BiswalRosalin BiswalJuly 7, 2026
Kunal Kapoor with Ketto Co-founders Launch Metabolic Health Startup MetaGO

Actor and entrepreneur Kunal Kapoor, along with Ketto co-founders Varun Sheth and Zaheer Adenwala, has launched MetaGO, a doctor-led metabolic health platform focused on helping people manage obesity and related metabolic disorders through personalised, preventive, and continuous medical care.

MetaGO aims to shift metabolic healthcare from reactive treatment to early intervention by combining comprehensive diagnostics, specialist consultations, personalised nutrition guidance, fitness coaching, prescription-based GLP-1 therapies where clinically appropriate, and continuous medical monitoring.

The idea for MetaGO emerged from the founders’ experience building Ketto, one of India’s leading healthcare crowdfunding platforms. Over the past 14 years, the team has worked with thousands of families raising funds for treatments related to diabetes, cardiovascular disease, obesity, and other metabolic conditions. According to the founders, many of these illnesses could have been prevented or managed more effectively through timely intervention and long-term care.

Explaining the motivation behind the venture, Kunal Kapoor said, 

“Fourteen years of building Ketto teaches you to see patterns. We met thousands of families at some of the hardest moments of their lives. Many were facing diseases that had quietly progressed over years. That’s what led to MetaGO. We’re not building a weight-loss company. We’re building a metabolic health company focused on the years when the right intervention is a doctor’s consultation instead of a surgery.” 

He further added,

“GLP-1 therapies have genuinely changed what’s possible for many people living with obesity, but medication is only one part of the journey. Lasting outcomes come from combining it with medical supervision, nutrition, behaviour change, and ongoing support. Nobody should be left alone with a strong drug and a printout.” 

Founded in 2012, Ketto has grown into one of India’s largest healthcare crowdfunding platforms, enabling patients to raise funds for critical medical treatments through donations from individuals, corporates, and philanthropic organisations.

Beyond his acting career, Kunal Kapoor has also established himself as an entrepreneur and active angel investor, backing startups across sectors including healthcare, artificial intelligence, robotics, and consumer technology.

At MetaGO, every member begins with a comprehensive metabolic assessment covering more than 35 biomarkers, followed by a detailed clinical evaluation. Based on these results, specialists including endocrinologists, diabetologists, cardiologists, and internal medicine physicians develop personalised treatment plans tailored to each individual’s metabolic profile and long-term health goals.

Rather than positioning GLP-1 medications as standalone weight-loss solutions, MetaGO integrates them into a broader physician-led care model that includes regular doctor consultations, nutrition coaching, fitness guidance, behavioural support, and continuous health monitoring to help members achieve sustainable outcomes.

As part of its community outreach efforts, MetaGO recently organised a free metabolic health camp for the Mumbai Police, offering blood tests and physician consultations. The startup plans to expand similar initiatives to other professional groups to raise awareness about metabolic health and preventive care.

Commenting on the broader vision, co-founder Varun Sheth said,

“India has made remarkable progress in expanding access to healthcare. The next frontier is ensuring people receive continuous, preventive care before chronic conditions become life-threatening. That’s the gap MetaGO is designed to address.” 

MetaGO enters India’s rapidly evolving preventive healthcare market at a time when obesity, Type 2 diabetes, cardiovascular diseases, PCOS, and other lifestyle-related disorders are on the rise.